Bone cancer in dogs, most commonly osteosarcoma, results from a combination of genetic mutations, rapid skeletal growth, and physical stress on weight-bearing bones. It overwhelmingly affects large and giant breeds, with dogs over 45 kg facing more than 20 times the risk of smaller dogs. No single cause has been identified, but researchers have pinpointed several factors that work together to trigger malignant bone cell growth.
Why Large and Giant Breeds Are Most at Risk
Size is the single strongest predictor of bone cancer in dogs. Larger bodies require more bone cell divisions during growth and throughout life to maintain and remodel the skeleton. Each cell division carries a small chance of a copying error in DNA, and more divisions mean more opportunities for a dangerous mutation to take hold. Dogs that grow quickly to a large adult size concentrate this risk into a relatively short window, making the adolescent growth period especially critical.
A study of Leonbergers found that puppies who were heavier during their growth phase were significantly more likely to develop bone cancer later in life. At 12 and 18 months of age, each additional kilogram of body weight raised the odds of a future bone cancer diagnosis by roughly 20%. A larger circumference of the lower leg bones at 18 months was associated with a nearly 70% increase in risk per centimeter. These findings support the idea that weight-bearing stress during periods of high bone cell activity is a key contributor.
The forelimbs, which carry about 60% of a dog’s total body weight, are the most common location for bone tumors. Of 744 dogs with appendicular osteosarcoma in one large study, 64% had tumors in a forelimb. The most frequently affected individual bone was the humerus (upper arm), followed by the femur (thigh) and radius (forearm). Tumors tend to develop at or near growth plates, the zones where bone cells divide most rapidly during development.
Breeds With the Highest Risk
A large-scale study from the Royal Veterinary College quantified just how dramatically risk varies by breed. Scottish Deerhounds were 118 times more likely to develop osteosarcoma than crossbreed dogs, with 3.28% of all Deerhounds affected each year. Leonbergers were 56 times more likely, Great Danes 34 times, and Rottweilers 27 times. These numbers reflect a combination of body size and inherited genetic vulnerability specific to each breed’s gene pool.
Other commonly affected breeds include Greyhounds, Golden Retrievers, Irish Wolfhounds, and Saint Bernards. The concentration of risk in certain breed lines tells researchers that specific inherited mutations, not just size alone, play a role. Two Rottweilers of identical weight can have different risk profiles depending on their family history.
Genetic Mutations Behind Tumor Growth
Whole-exome sequencing of osteosarcoma tumors from Golden Retrievers, Rottweilers, and Greyhounds has revealed a detailed genetic picture. The tumors carry a high number of large-scale DNA rearrangements affecting genes that normally control cell growth and suppress tumor formation.
The gene TP53, which acts as a critical brake on uncontrolled cell division, was altered in 83% of the dogs studied, either through direct mutations or through chunks of the gene being deleted or duplicated. This mirrors what happens in human osteosarcoma. The second most commonly mutated gene was SETD2, a gene involved in how cells package and read their DNA. It was mutated in 21% of tumors overall, with Golden Retrievers showing the highest rate at 32%. Other frequently disrupted genes included CDKN2A/B, PTEN, and HRAS, all of which are well-known players in various cancers. Researchers also identified mutations in genes not previously linked to bone cancer, including HIPK2 and EDNRB, which were altered in more than 80% of samples across all three breeds.
These mutations aren’t inherited in a simple, one-gene pattern. Instead, dogs in high-risk breeds likely inherit a combination of subtle genetic variants that make their bone cells more vulnerable. The actual tumor-triggering mutations then accumulate over the dog’s lifetime, especially during periods of rapid bone growth and remodeling.
Previous Injuries and Metal Implants
Bone trauma and surgical hardware can act as localized triggers for tumor development, though this accounts for a small fraction of cases overall. Tumors that develop near old fracture sites or metal plates are a recognized phenomenon in both dogs and humans. Several mechanisms likely contribute: chronic low-grade inflammation from the healing process, irritation from loose or corroding metal components, and the sustained cell turnover needed to repair damaged bone.
Metal implant corrosion may release particles that directly damage the DNA of surrounding cells. Loose hardware, particularly cerclage wires (thin metal wires wrapped around bone), can create ongoing micromotion and tissue irritation that promotes tumor-friendly inflammation. One study at a veterinary referral hospital found that dogs with additional wire implants alongside bone plates had a statistically higher rate of aggressive bone lesions. The time gap between the original injury and tumor appearance is typically long, often years, which is consistent with the slow accumulation of genetic damage rather than a single triggering event.
Chronic bone infections and bone infarcts (areas where blood supply is disrupted) have also been proposed as promoters of malignancy, though these remain relatively rare causes compared to the genetic and size-related factors.
The Role of Rapid Growth and Cell Turnover
The underlying biology ties all these risk factors together. Osteosarcoma originates from bone-forming cells called osteoblasts, which are thought to arise from a type of multipurpose stem cell in the bone marrow. Under normal conditions, these stem cells divide, mature into osteoblasts, and build or repair bone in a tightly controlled process. When that control breaks down through accumulated mutations, the result is a cell that divides without restraint and forms a malignant tumor instead of healthy bone.
Anything that increases the rate of bone cell division increases the odds of this going wrong. Rapid adolescent growth, bearing heavy body weight, repairing a fracture, and remodeling bone around an implant all push bone cells to divide more frequently. This is why veterinary nutritionists recommend controlling energy intake in large-breed puppies to slow their growth rate and reduce the risk of developmental bone disease, including cancer.
What About Spaying and Neutering?
The question of whether early spaying or neutering raises bone cancer risk has generated significant debate. Sex hormones influence when growth plates close, so removing them early can result in slightly longer bones and a longer period of active bone growth, both of which could theoretically increase osteosarcoma risk. Some earlier breed-specific studies suggested a link, particularly in Rottweilers.
However, a large study across mixed-breed dogs in five weight categories found no significant increase in osteosarcoma or other cancers in neutered dogs compared to intact dogs, regardless of the age at neutering. The researchers noted that the diversity of genetic backgrounds in mixed breeds likely dilutes breed-specific vulnerabilities. For purebred dogs in high-risk breeds, the picture may differ, and the decision about when to neuter involves weighing multiple health considerations beyond bone cancer alone.
Age and When Tumors Typically Appear
Most dogs are diagnosed with osteosarcoma between 7 and 10 years of age, though it can appear earlier in giant breeds. The long gap between the adolescent growth period (when many of the critical mutations likely accumulate) and the eventual tumor diagnosis reflects the years it takes for enough genetic damage to pile up and for a single rogue cell to grow into a detectable mass. Dogs under 25 kg rarely develop osteosarcoma, and when small dogs do get bone tumors, the tumors tend to behave somewhat differently and occur in axial locations like the skull or spine rather than the limbs.